NCT03541668

Phase 3Interventional

Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.

View on ClinicalTrials.gov ↗

Timeline

Start date: May 18, 2018
Primary completion: Mar 18, 2022
Completion date: Aug 18, 2022
First posted: —
Last posted: —
Enrollment: 700
Arms / groups: 2 / —
Source: AACT · ingestion pipeline

Drugs studied

alteplase
urokinase

Indications studied

Stroke

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.

NCT03541668

Timeline

Sponsors

Drugs studied

Indications studied